Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Three-way Cross Over Study to Determine the Optimal Absorption of an Omega-3 Supplement Administered as a Single Oral Dose to Healthy Volunteers

NCT05491759 is registered in ClinicalTrials.gov with RDC Clinical Pty Ltd as lead sponsor.

NCT NCT05491759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05491759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Three-way Cross Over Study to Determine the Optimal Absorption of an Omega-3 Supplement Administered as a Single Oral Dose to Healthy Volunteers
Lead sponsor
RDC Clinical Pty Ltd
Phase
Phase 4
Overall status
Completed
Start date
August 4, 2022
Completion date
September 28, 2022
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

optimal gastrointestinal absorption of omega-3